What happens when the very same companies that provide life-saving drugs violate some children's rights to improve health care for others, or simply to increase the bottom line? As the pharmaceutical industry becomes increasingly globalised, it is ever more important to ask this question. Over the past several years, lawsuits and investigations have cropped up around the world that raise concerns about not only testing drugs on children, but administering untested or unnecessary drugs on children. This editorial offers a review of these concerns.
© 2020 IICRD - web design by Virtual Wave Media